Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age

NCT04474457 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Favipiravir

Sponsor

Ministry of Health, Turkey

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]